One Patient, Two Problems: Applying Short Bowel Syndrome Management Principles in Inflammatory Bowel Disease patients. [PDF]
Chiplunker AJ +3 more
europepmc +1 more source
Updates in the Management of Short Bowel Syndrome Secondary to Intestinal Resection in the Pediatric Population. [PDF]
Gafton-Oghină AL +9 more
europepmc +1 more source
Beyond intestinal failure: Expanding therapeutic frontiers of glucagon-like peptide-2 in gastrointestinal disease. [PDF]
Attieh P +5 more
europepmc +1 more source
Effectiveness and Safety of Teduglutide Treatment in Adult Patients with Short Bowel Syndrome: A Case Series and Review of Current Evidence. [PDF]
Fousekis F +12 more
europepmc +1 more source
Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome. [PDF]
Pathania J, Pathania V.
europepmc +1 more source
EVIDENCE OF THE INFLUENCE OF GLUCAGON-LIKE PEPTIDE ANALOGS IN INFLAMMATORY BOWEL DISEASE: A SCOPING REVIEW. [PDF]
Rezende LDA +5 more
europepmc +1 more source
Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation. [PDF]
Lu J, Chen K.
europepmc +1 more source
Loss of GLP-2R signaling in Glp2r<sup>-/-</sup> mice increases the long-term severity of graft versus host disease. [PDF]
Yusta B +5 more
europepmc +1 more source
Six-Month Safety and Effectiveness of Teduglutide in Patients with Short Bowel Syndrome in Japan: Interim Analysis of Post-marketing Surveillance. [PDF]
Wada M +5 more
europepmc +1 more source
Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina. [PDF]
Solar Muñiz H +19 more
europepmc +1 more source

